- Home
- USA vs STAA Comparison
USA vs STAA Comparison
Compare USA & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USA | STAA |
|---|---|---|
| Founded | N/A | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 1994 | 1995 |
Fundamental Metrics
Financial Performance| Metric | USA | STAA |
|---|---|---|
| Price | $5.98 | $23.60 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $22.81 |
| AVG Volume (30 Days) | ★ 1.1M | 780.9K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | N/A | $30.82 |
| Revenue Next Year | N/A | $8.41 |
| P/E Ratio | ★ N/A | $89.04 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.40 | $15.59 |
| 52 Week High | $6.56 | $35.87 |
Technical Indicators
Market Signals| Indicator | USA | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 57.16 | 44.32 |
| Support Level | $5.65 | $22.55 |
| Resistance Level | $6.11 | $26.21 |
| Average True Range (ATR) | 0.05 | 0.97 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 59.37 | 32.94 |
Price Performance
Historical ComparisonAbout USA Liberty All-Star Equity Fund
Liberty All Star Equity Fund is a diversified, closed-end management investment company. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.